Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP906803.RAqced1_R52c1WuyCj1uRKy5ai1T0_tWYCCQInmMnW_wc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP906803.RAqced1_R52c1WuyCj1uRKy5ai1T0_tWYCCQInmMnW_wc130_assertion type Assertion NP906803.RAqced1_R52c1WuyCj1uRKy5ai1T0_tWYCCQInmMnW_wc130_head.
- NP906803.RAqced1_R52c1WuyCj1uRKy5ai1T0_tWYCCQInmMnW_wc130_assertion description "[We show that quinacrine synergizes with 5-fluorouracil and significantly enhances the cytotoxicity of sorafenib in a panel of 10 human colorectal cancer cell lines, including those with KRAS mutations protein gel blot analysis confirmed that quinacrine's anticancer activity partially arises from its ability to stabilize p53 and lower anti-apoptotic protein levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906803.RAqced1_R52c1WuyCj1uRKy5ai1T0_tWYCCQInmMnW_wc130_provenance.
- NP906803.RAqced1_R52c1WuyCj1uRKy5ai1T0_tWYCCQInmMnW_wc130_assertion evidence source_evidence_literature NP906803.RAqced1_R52c1WuyCj1uRKy5ai1T0_tWYCCQInmMnW_wc130_provenance.
- NP906803.RAqced1_R52c1WuyCj1uRKy5ai1T0_tWYCCQInmMnW_wc130_assertion SIO_000772 21725213 NP906803.RAqced1_R52c1WuyCj1uRKy5ai1T0_tWYCCQInmMnW_wc130_provenance.
- NP906803.RAqced1_R52c1WuyCj1uRKy5ai1T0_tWYCCQInmMnW_wc130_assertion wasDerivedFrom befree-2016 NP906803.RAqced1_R52c1WuyCj1uRKy5ai1T0_tWYCCQInmMnW_wc130_provenance.
- NP906803.RAqced1_R52c1WuyCj1uRKy5ai1T0_tWYCCQInmMnW_wc130_assertion wasGeneratedBy ECO_0000203 NP906803.RAqced1_R52c1WuyCj1uRKy5ai1T0_tWYCCQInmMnW_wc130_provenance.